BioMarin Pharmaceutical Inc. · 9 hours ago
Senior FP&A Manager, Supply Chain
BioMarin Pharmaceutical Inc. is a global biotechnology company focused on developing transformative medicines for genetic conditions. They are seeking a Senior FP&A Manager to provide strategic financial support to the Global Supply Chain organization, partnering with leadership to optimize financial performance and drive process improvements.
BiotechnologyDeveloper PlatformPharmaceutical
Responsibilities
Key participant in the Sales & Operations Planning (S&OP) process, ensuing that product supply plans are in accordance with long-term profitability and cash-flow targets. Provide financial analysis & scenario modeling to support informed supply and network decision making
Optimize working capital utilization across BMRN’s commercial and clinical supply chain networks. Provide data-driven financial insights on historical activity and recommendations for last-mile distribution and general logistics spend
Partner with Supply Chain leadership to develop and deliver annual budgets, quarterly forecasts, and long-range plans, ensuring alignment with BioMarin’s strategic objectives
Lead monthly and quarterly financial reviews, presenting performance analysis, identifying drivers of variances, and recommending actions for improvement
Drive process improvements in financial reporting, forecasting, and analysis to enhance accuracy, efficiency, and business insight
Collaborate with cross-functional teams, including Operations, Procurement, Manufacturing, Commercial Finance, and Corporate Finance, to ensure cohesive financial planning and execution
Monitor and report on key performance indicators (KPIs) relevant to supply chain efficiency, working capital, and cost optimization
Mentor and develop junior finance team members, fostering a culture of continuous improvement and professional growth
Qualification
Required
Bachelor's degree in Finance, Accounting, Business, or a related field; advanced degree or professional qualification (e.g., ACA, ACCA, CIMA, CPA) preferred
Minimum of 7 years' experience in FP&A or financial analysis roles, with at least 3 years supporting supply chain, manufacturing, or operations functions, ideally within the pharmaceutical or biotech sectors
Strong analytical skills, with expertise in financial modelling, forecasting, and performance management
Proficient in ERP and financial planning systems (e.g., SAP, Oracle, Hyperion, Anaplan), with advanced Excel skills
Demonstrated ability to translate financial data into actionable insights for senior management
Excellent communication, presentation, and interpersonal skills, with a proven track record of business partnering and influencing cross-functional stakeholders
High attention to detail, strong organizational skills, and the ability to manage multiple priorities in a fast-paced environment
Knowledge of supply chain processes, inventory management, and cost accounting principles
Preferred
Experience in a global, matrixed organization
Familiarity with pharmaceutical industry regulations and compliance requirements
Innovative mindset, with a drive for continuous improvement and operational excellence
Benefits
Discretionary annual bonus
Discretionary stock-based long-term incentives (eligibility may vary based on role)
Paid time off
Company-sponsored medical, dental, vision, and life insurance plans
Company
BioMarin Pharmaceutical Inc.
Founded in 1997, BioMarin is a global biotechnology company dedicated to transforming lives through genetic discovery.
H1B Sponsorship
BioMarin Pharmaceutical Inc. has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (34)
2024 (23)
2023 (24)
2022 (26)
2021 (24)
2020 (19)
Funding
Current Stage
Public CompanyTotal Funding
$585.8M2020-05-11Post Ipo Debt· $585.8M
1999-07-26IPO
Leadership Team
Recent News
Bizjournals.com Feed (2025-11-12 15:43:17)
2026-01-23
Company data provided by crunchbase